June 2020
Volume 33, No. 6 |
|
|
|
|
|
|
Notice to BioPharm International subscribers currently receiving printed copies of the magazine:
Many readers working remotely may not have access to the print versions of BioPharm International; therefore, for upcoming issues, we will deliver the digital version of the magazine to you via email. Your print issues will continue to be delivered to you via postal mail and will be awaiting your return to the office. If you wish to change your delivery address, or delivery preference, you can do so via our online subscription form.
|
| |
| COVER STORY |
Jennifer Markarian
Automated sampling systems and integration of PAT are overcoming some of the roadblocks to increased automation of biopharmaceutical manufacturing processes.
read more
| UPSTREAM PROCESSING |
Cynthia A. Challener
Therapies for early and late treatment and passive immunization of COVID-19 are needed and can be developed using antibodies from recovered patients.
read more
| DOWNSTREAM PROCESSING |
Feliza Mirasol
Tools such as manufacturing execution systems, artificial intelligence, and software innovations are useful for enhancing data integrity protection.
read more
|
|
ADVERTISEMENT
Featured Resources from BioPharm International
View our online resource center, sponsored by GE Healthcare, to explore a case study and articles on gaining and retaining skilled labor, modular bioprocessing, the good and bad of biosilimiars, and more.
Learn More »  |
|
|
| BioPharm International June Issue
|
|
| PEER-REVIEW RESEARCH |
Jun Luo, Sid Kundu, Yiming Peng, Jesse Bergevin
Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.
read more
|
| OPERATIONS |
Agnes Shanley
The COVID-19 pandemic has led to increased demand for direct-to-patient shipments, challenging cold-chain specialists to become more agile and to strengthen their global distribution networks.
read more
| ANALYTICS |
Feliza Mirasol
Bioanalytical studies are an important aspect of biologic drug development that may necessitate partnering with bioanalysis experts.
read more
| BIOBUSINESS |
Lauren Lavelle
Working with incubators can provide cell and gene therapy developers with more opportunities.
read more
|
|
|
|
| FROM THE EDITOR |
Rita C. Peters
Achieving herd immunity will require testing, data, a vaccine, and public support.
read more
| REGULATORY BEAT |
Jill Wechsler
FDA and the US Congress support innovation and access to cheaper medicines.
read more
| ASK THE EXPERT |
Susan J. Schniepp
Products must be manufactured in accordance with appropriate regulatory requirements, even during a pandemic, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
read more
|
|
| EVENTS |
June 8–12, 2020
August 24–26, 2020
September 30–October 2, 2020
more events
|
|
|
|
|
|
|
